Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Contacts | Advertise | Login 
 
Search Article 
  
Advanced search 
  Users Online: 274 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  

    Article Cited by others

ORIGINAL ARTICLE

Pioglitazone and the risk of bladder cancer: An Indian retrospective cohort study

Gupta Sunil, Gupta Kavita, Ravi R, Mehta Vinita, Banerjee Samar, Joshi Shashank, Saboo Banshi

Year : 2015| Volume: 19| Issue : 5 | Page no: 639-643

   This article has been cited by
 
1 Pioglitazone and risk of bladder cancer in type 2 diabetes mellitus patients: A systematic literature review and meta-analysis of observational studies using real-world data
Mohammad Adil,Rashid Ali Khan,Pinaki Ghosh,Shiva Kumar Venkata,Amit Dattatraya Kandhare,Manju Sharma
Clinical Epidemiology and Global Health. 2017;
[Pubmed]  [Google Scholar] [DOI]
2 Thiazolidinedione drugs in the treatment of type 2 diabetes mellitus: past, present and future
Melissa A. Davidson,Donald R. Mattison,Laurent Azoulay,Daniel Krewski
Critical Reviews in Toxicology. 2017; : 1
[Pubmed]  [Google Scholar] [DOI]
3 Global and Regional Effects of Bladder Cancer Risk Associated with Pioglitazone Therapy in Patients with Diabetes
Hua Qu,Yi Zheng,Yuren Wang,Rui Zhang,Xiongzhong Ruan,Gangyi Yang,Zhenqi Liu,Hongting Zheng
Scientific Reports. 2017; 7(1)
[Pubmed]  [Google Scholar] [DOI]
4 Pioglitazone and the Risk of Bladder Cancer: A Meta-Analysis
Elena Filipova,Katya Uzunova,Krassimir Kalinov,Toni Vekov
Diabetes Therapy. 2017;
[Pubmed]  [Google Scholar] [DOI]
5 Methods for determining neurotransmitter metabolism markers for clinical diagnostics
I. A. Veselova,E. A. Sergeeva,M. I. Makedonskaya,O. E. Eremina,S. N. Kalmykov,T. N. Shekhovtsova
Journal of Analytical Chemistry. 2016; 71(12): 1155
[Pubmed]  [Google Scholar] [DOI]

 

Read this article